Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201102474 Principal Investigator: Waqar, Saiama
Title: A Phase 1/2 Maximum Tolerated Dose Study of Belinostat (PXD-101) in Combination with Paclitaxel plus Carboplatin in Chemotherapy-Naive Patients with Stage IV Non-Small-Cell Lung Cancer
Phase: I/II Disease Site: Lung
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu
Description:
The primary purpose of this research study is to find a safe dose based on side effects of the investigational drug, belinostat, in combination with carboplatin and paclitaxel.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)